PT3035941T - Utilização de uma molécula de mir172 para reduzir a inflamação - Google Patents

Utilização de uma molécula de mir172 para reduzir a inflamação

Info

Publication number
PT3035941T
PT3035941T PT14766010T PT14766010T PT3035941T PT 3035941 T PT3035941 T PT 3035941T PT 14766010 T PT14766010 T PT 14766010T PT 14766010 T PT14766010 T PT 14766010T PT 3035941 T PT3035941 T PT 3035941T
Authority
PT
Portugal
Prior art keywords
decreasing inflammation
mir172
molecule
mir172 molecule
inflammation
Prior art date
Application number
PT14766010T
Other languages
English (en)
Inventor
Lukasik Anna
Zielenkiewicz Piotr
Szweykowska-Kulinska Zofia
Paczek Leszek
Nowaczyk Maria
Original Assignee
Inst Biochemii I Biofizyki Pan
Univ Im Adama Mickiewicza W Poznaniu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Biochemii I Biofizyki Pan, Univ Im Adama Mickiewicza W Poznaniu filed Critical Inst Biochemii I Biofizyki Pan
Publication of PT3035941T publication Critical patent/PT3035941T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering N.A.
    • C12N2310/141MicroRNAs, miRNAs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT14766010T 2013-08-23 2014-08-13 Utilização de uma molécula de mir172 para reduzir a inflamação PT3035941T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL405125A PL226431B1 (pl) 2013-08-23 2013-08-23 Cząsteczka miRNA do zastosowania do wytwarzania leku do zmniejszania reakcji zapalnej lub zapobiegania zwiększaniu się reakcji zapalnej organizmu

Publications (1)

Publication Number Publication Date
PT3035941T true PT3035941T (pt) 2018-12-24

Family

ID=51539311

Family Applications (1)

Application Number Title Priority Date Filing Date
PT14766010T PT3035941T (pt) 2013-08-23 2014-08-13 Utilização de uma molécula de mir172 para reduzir a inflamação

Country Status (13)

Country Link
US (1) US20160272966A1 (pt)
EP (1) EP3035941B1 (pt)
CY (1) CY1121427T1 (pt)
DK (1) DK3035941T3 (pt)
ES (1) ES2702638T3 (pt)
HR (1) HRP20182115T1 (pt)
HU (1) HUE041520T2 (pt)
LT (1) LT3035941T (pt)
PL (1) PL226431B1 (pt)
PT (1) PT3035941T (pt)
RS (1) RS58431B1 (pt)
SI (1) SI3035941T1 (pt)
WO (1) WO2015026249A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3842535A1 (en) * 2014-04-30 2021-06-30 Fondazione Edmund Mach Plant srna extract or plant mirna for use as immunosuppressive agent
EP3216869B1 (en) 2016-03-09 2019-09-18 Colizzi, Vittorio Nutraceutical plant derived microrna elements for treatment of leukemia
EP3551046B1 (en) 2016-12-07 2023-07-19 Biora Therapeutics, Inc. Gastrointestinal tract detection methods, devices and systems
US20190343425A1 (en) 2016-12-14 2019-11-14 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with a tnf inhibitor
EP3810095A1 (en) 2018-06-20 2021-04-28 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with a tnf inhibitor
KR20210095165A (ko) 2018-11-19 2021-07-30 프로제너티, 인크. 바이오의약품으로 질환을 치료하기 위한 방법 및 디바이스
CN115666704A (zh) 2019-12-13 2023-01-31 比奥拉治疗股份有限公司 用于将治疗剂递送至胃肠道的可摄取装置

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4006768A1 (de) 1990-03-03 1991-09-05 Karatzanos Timoleon Entzuendungshemmendes und schmerzlinderndes mittel, insbesondere rheumamittel
EP1478730A4 (en) 2002-02-20 2006-01-25 Sirna Therapeutics Inc INTERFERENCE RNA-INDUCED INHIBITION OF THE GENE EXPRESSION OF SUPERFAMILY TFN AND TFN RECEPTOR SUPERFAMILY USING SHORT INTERFERENCE NUCLEIC ACID (SINA)
JP4410451B2 (ja) 2002-03-15 2010-02-03 株式会社ファンケル 抗アレルギー、抗炎症用組成物
EP2371859A3 (en) 2002-07-19 2011-12-28 Abbott Biotechnology Ltd Treatment of TNF alpha related disorders
PL378879A1 (pl) 2002-12-30 2006-05-29 Amgen Inc. Terapia skojarzona z czynnikami kostymulującymi
US20060218673A9 (en) * 2003-10-09 2006-09-28 E.I. Du Pont De Nemours And Company Gene silencing
US8231872B2 (en) 2005-04-25 2012-07-31 The Trustees Of Dartmouth College Regulatory T cell mediator proteins and uses thereof
AU2012201409B2 (en) 2006-05-19 2014-06-12 Arrowhead Research Corporation RNAi-Mediated inhibition of tumor necrosis factor alpha-related conditions
AU2008232316A1 (en) * 2007-03-26 2008-10-02 Newcastle Innovation Limited Therapeutic targets and molecules
US20100202973A1 (en) * 2007-05-18 2010-08-12 Karolinska Institutet Innovations Ab Microrna molecules associated with inflammatory skin disorders
US20120093936A1 (en) * 2009-04-07 2012-04-19 Velin-Pharma A/S Method and device for treatment of conditions associated with inflammation or undesirable activation of the immune system
WO2010151755A2 (en) * 2009-06-25 2010-12-29 The Brigham And Women's Hospital, Inc. TREATMENT OF INFLAMMATORY DISEASES USING miR-124
KR101090177B1 (ko) 2010-06-03 2011-12-06 건국대학교 산학협력단 인터류킨­32 길항적 rna 앱타머
KR101263356B1 (ko) 2011-02-23 2013-05-16 정종문 항염증용 식품 조성물
WO2012153854A1 (ja) 2011-05-12 2012-11-15 学校法人立命館 サイトカイン・ケモカインモジュレーター
CN102887948B (zh) 2012-08-24 2014-06-11 复旦大学附属儿科医院 一种抗菌及免疫调节多肽类药物

Also Published As

Publication number Publication date
LT3035941T (lt) 2019-02-11
WO2015026249A1 (en) 2015-02-26
US20160272966A1 (en) 2016-09-22
CY1121427T1 (el) 2020-05-29
EP3035941A1 (en) 2016-06-29
EP3035941B1 (en) 2018-10-03
ES2702638T3 (es) 2019-03-04
HRP20182115T1 (hr) 2019-03-22
DK3035941T3 (en) 2019-01-14
RS58431B1 (sr) 2019-04-30
HUE041520T2 (hu) 2019-05-28
PL405125A1 (pl) 2015-03-02
WO2015026249A8 (en) 2017-06-15
PL226431B1 (pl) 2017-07-31
SI3035941T1 (sl) 2019-04-30

Similar Documents

Publication Publication Date Title
HK1221224A1 (zh) 依洛昔巴特的結晶修飾物
EP3023769A4 (en) SPECTROSCOPE
HRP20182115T1 (hr) UPORABA MOLEKULE miR172 ZA SMANJENJE UPALE
HUE047186T2 (hu) Új alkalmazás
HRP20181710T1 (hr) Uporaba derivata benzimidazol-prolina
GB201305825D0 (en) New use
GB201320932D0 (en) Topical pharmaceutical composition
DK2975989T3 (da) Dispenseranordning
EP2948129A4 (en) THERAPEUTIC COMPOUNDS
GB201319109D0 (en) Anti-inflammatory solution
GB201314286D0 (en) Therapeutic Compounds
GB201312499D0 (en) Therapeutic compounds
GB201320905D0 (en) Therapeutic compounds
HK1211843A1 (en) Anti-inflammatory agent
GB201321316D0 (en) Pharmaceutical Compound
GB201320349D0 (en) New therapeutic use
GB201320786D0 (en) Medicament
GB201309405D0 (en) Pharmaceutical compound
AU2013900154A0 (en) Use of anti-fungal defensins
GB201314397D0 (en) Therapeutic Compounds
GB201311905D0 (en) Bandage
GB201311169D0 (en) Therapeutic compounds
GB201306453D0 (en) Anti-inflammatory compounds